UNBX — Unity Biotechnology Share News
0.000.00%
Last trade - 00:00Unity Biotech hits record low after eye drug fails in mid-stage study
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
Unity Biotech falls after eye drug fails in mid-stage study
Brief: UNITY Biotech Announces Results From Phase 2 Envision Study Of UBX1325
Brief: Unity Biotechnology Results From Phase 2 Study Of UBX1325 In Patients With Wet Age-Related Macular Degeneration
Unity Biotechnology Inc Reports Results For The Quarter Ended In December: Earnings Summary
Brief: Unity Biotechnology, Inc. Reports Q4 And Full Year 2022 Financial Results And Business Updates
Brief: Unity Biotechnology Considers Exposure To Liquidity Concern At SVB
Unity Biotechnology Inc Expected To Post A Loss Of $1.05 A Share: Earnings Preview
Brief: Unity Biotechnology Inc Expects Data From Mid-Stage Envision Study In Wet AMD In Q1 2023
Unity Biotechnology Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: UNITY Biotechnology Reports Q3 2022 Results
Unity Biotechnology Inc Expected To Post A Loss Of $1.65 A Share: Earnings Preview
U.S. STOCKS ON THE MOVE-Processa Pharma, CenterPoint Energy
U.S. STOCKS ON THE MOVE-Unity Bio, CONSOL Energy, Sofi Technologies
Unity Bio soars on positive mid-stage data for eye drug
Brief: Unity Biotechnology Announces Positive 24-Week Data From Phase 2 Behold Study Of UBX1325
Brief: Unity Biotechnology Announces Reverse Stock Split
Brief: Unity Biotechnology Files For Mixed Shelf Of Upto $250 Mln